Massachusetts Attorney General Approves Caritas Christi Sale

Massachusetts Attorney General Martha Coakley has approved the sale of Boston-based non-profit Caritas Christi Health Care to private equity firm Cerberus Capital Management, saying the system could not continue to survive in its current form, according to a Boston Business Journal report.

Advertisement

The deal is one of a few recent high-profile transactions of non-profit systems by for-profit companies. For-profit companies traditionally have more capital for acquisitions. These deals, however, often require additional regulatory approval since the non-profit status of the entity would transfer to for-profit.

Attorney General Coakley ruled in favor of the deal after a five month review, but will require Cerberus to preserve the jobs and fully fund the pensions of current and former Caritas employees. In addition, Cerberus must commit no less than $400 million to capital improvements over four years as well as commit to keeping open all Caritas facilities for a period of five years, providing certain financial margins are met, according to the report.

The original deal, valued at $830 million, was announced in March.

Read the Boston Business Journal report on Caritas Christi.

Read more coverage on Caritas Christi:

Boston’s Caritas Christi to Close Two Hospitals if Cerberus Deal Fails

Competitors of Caritas Christi Seek Strict Rules for the System Following Sale to For-Profit Firm

Massachusetts Will Hold Hearings on Selling Caritas Christi to For-Profit Group

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.